Description:
CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company is headquartered in Vienna, Virginia.
Address:
8229 BOONE BOULEVARD, VIENNA, VA, UNITED STATES, 22182
Fiscal year end:
September
Market capitalization:
$20.7 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-99%
How much will you get:
$7
Prices dates:
29-04-2016: $412.50 and 30-04-2026: $3.07